Fundraising Fox
Synthego
Redwood City, US · Founded 2012 · Delaware corporation · 176 employees on LinkedIn · 24 known investors
Find your way into Synthego
Sign up to see every warm intro you have to Synthego
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synthego team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.
Founders & leadership
Synthego was founded in 2012 by Paul John Dabrowski and Michael Jakub Dabrowski.
Board
Investors · 24
How we know: AAF Management Ltd.'s portfolio page · the VCSheet dataset · Not right? Tell us
How we know: AME Cloud Ventures's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Declaration Partners's portfolio page · funding news · synthego.com · Not right? Tell us
How we know: Founders Fund's portfolio page · board seat on SEC Form D · funding news · Not right? Tell us
How we know: Khosla Ventures's portfolio page · Not right? Tell us
How we know: Menlo Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: Perot Jain's portfolio page · Not right? Tell us
How we know: hrnxt.com · Not right? Tell us
How we know: WI Harper Group's portfolio page · Not right? Tell us
How we know: Wormhole Capital's portfolio page · Not right? Tell us
How we know: funding news · finance.yahoo.com · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: synthego.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · synthego.com · Not right? Tell us
Also in the syndicate · 6
Funding
SEC filings, press & company announcements$247M disclosed across 3 of 6 rounds · 2016–2025
- Undisclosed amountSeries EFeb 2022
Perceptive Advisors (lead), Chimera Abu Dhabi, Declaration Partners, GigaFund, Laurion Capital Management, Logos Capital, Moore Strategic Ventures, RA Capital Management, SoftBank Vision Fund 2, Wellington Management
Source ↗ - $100MSeries DAug 2020 · 2 sources
Wellington Management (lead)
Source ↗
▶$106.3MraisedOct 2018 · 29 investors · BiotechnologyRule 506(b)
- Drew OettingDirector
- Scott NolanDirector
- Michael Jakub DabrowskiExecutive Officer, Director
- Forrest Baringer-JonesExecutive Officer
- Paul John DabrowskiExecutive Officer, Director
- Offering amount
- $116.3M
- Amount sold
- $106.3M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.7MraisedJan 2017 · 22 investors · BiotechnologyRule 506(b)
- Paul John DabrowskiExecutive Officer, Director
- Michael Jakub DabrowskiExecutive Officer, Director
- Drew OettingDirector
- Scott NolanDirector
- Offering amount
- $40.7M
- Amount sold
- $40.7M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
10 people who came through Synthego went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Synthego.
In the news
Frequently asked questions
- What does Synthego do?
- Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.
- Who founded Synthego?
- Synthego was founded by Paul John Dabrowski, Michael Jakub Dabrowski in 2012.
- Who are Synthego's investors?
- Synthego's investors include AAF Management Ltd., AME Cloud Ventures, Declaration Partners, Founders Fund, Khosla Ventures, Menlo Ventures, Open Field Capital, Perot Jain and 10 more.
- How much funding has Synthego raised?
- Synthego has disclosed $247M raised across 3 of its 6 known rounds.
- Where is Synthego headquartered?
- Synthego is headquartered in Redwood City, US.